Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.
about
Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathiesThe era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior.The pathophysiological relationship and clinical significance of left atrial function and left ventricular diastolic dysfunction in β-thalassemia major.MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.
P2860
Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Longitudinal monitoring of car ...... tion regimens: a 6-year study.
@ast
Longitudinal monitoring of car ...... tion regimens: a 6-year study.
@en
type
label
Longitudinal monitoring of car ...... tion regimens: a 6-year study.
@ast
Longitudinal monitoring of car ...... tion regimens: a 6-year study.
@en
prefLabel
Longitudinal monitoring of car ...... tion regimens: a 6-year study.
@ast
Longitudinal monitoring of car ...... tion regimens: a 6-year study.
@en
P2093
P2860
P356
P1476
Longitudinal monitoring of car ...... tion regimens: a 6-year study.
@en
P2093
Dorothy A Kleinert
Jonathan W Weinsaft
Kevin Mennitt
Patricia J Giardina
Rachel E Randolph
Srikanth R Ambati
P2860
P304
P356
10.1002/AJH.23469
P577
2013-06-28T00:00:00Z